Image

Global Gastritis Market – Industry Trends and Forecast to 2029

Pharmaceutical

Image

Global Gastritis Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Gastritis Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 162.20 Million
Diagram Market Size (Forecast Year) USD 221.98 Million
Diagram CAGR %

Major Markets Players

  • F. Hoffmann
  • La Roche Ltd.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi

Global Gastritis Market, By Treatment (Acid Blocking Medications, Acid Reducing Medications, Antacids, Antibiotics, Others), Type (Acute Gastritis, Chronic Gastritis, Erosive Gastritis, Non-Erosive Gastritis), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) – Industry Trends and Forecast to 2029.

Gastritis Market

Gastritis Market Analysis and Size

The gastritis market is expected to witness significant growth during the forecast period. The gastritis treatment market is projected to exhibit a healthy growth rate during the forecast period. There are numerous causes of gastritis but one of the most common causes is Helicobacter pylori, a bacterium that infects the stomach lining. If left untreated, gastritis caused by Helicobacter pylori can lead to ulcers and stomach cancer. Enlarged alcohol abuse and major market players are projected to boost the market forward. As per a published poll, nearly one in every 100 people in the U.S. suffers from gastritis.

Data Bridge Market Research analyses a growth rate in the global gastritis market in the forecast period 2022-2029. The expected CAGR of gastritis market is tend to be around 4% in the mentioned forecast period. The market was valued at USD 162.2 million in 2021, and it would grow upto USD 221.98 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Gastritis Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Treatment (Acid Blocking Medications, Acid Reducing Medications, Antacids, Antibiotics, Others), Type (Acute Gastritis, Chronic Gastritis, Erosive Gastritis, Non-Erosive Gastritis), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Sun Pharmaceutical Industries Ltd. (India), Merck & Co., Inc. (U.S.), Lilly (U.S.), Amgen Inc. (U.S.),Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), Lupin (India), Zydus Group (India)

Market Opportunities

  • High-end Efficiency of Biologics

Market Definition

Gastritis is the irritation, inflammation, or erosion of the stomach lining. It may be acute or chronic. The patient shows some symptoms or no symptoms at all. Typically, the symptoms include upper abdominal pain, nausea, and vomiting. Gastritis may lead to stomach tumors, bleeding, and stomach ulcers. Gastritis is generally caused by the bacteria helicobacter pylori or by the use of nonsteroidal anti-inflammatory drugs or NSAIDs. This disease prevalence is rising and important diagnostic procedures and treatments will boost the growth of the market.

Global Gastritis Market Dynamics

Drivers

  • Increased Gastrointestinal Disorders

As per the records of the Centers for Disease Control and Prevention (CDC), it is projected that around 1-1.3 million people are suffering from Inflammatory Bowel Disease (IBD) in U.S. Incidence of Crohn’s disease and ulcerative colitis is 201 per 100,000 adults and 238 per 100,000 adults, respectively. thus boosting the market growth.

  • Higher Rate of Drug Approvals and Launches       

An extensive range of new-generation therapeutics targets, including novel small molecules and cellular therapy, are currently under process. These include mongersen, tofacitinib, ustekinumab, and vedolizumab. This influx is expected to be a consequence of rising prevalence of gastrointestinal diseases worldwide. In addition to this, Vedolizumab is developing as a first-line biologic therapy for Crohn’s disease. Currently, the U.S. FDA has approved Humira, Amjevita, Remicade, Renflexis, Cimzia, Inflectra, Tysabri, and Entyvio for the treatment of Crohn’s disease. Thus, all these developments are boosting the growth of the market.

Opportunities

Some studies have specified that biologics show greater long-term efficiency. According to a study which University of Chicago conducted, it was witnessed that the usage of biologics has resulted in a complete reduction in the number of surgeries by around 40.0%, emergency room visits by 60.0%, and hospitalizations by 50.0%. All these factors are also contributing in the growth of the market.

Restraints/Challenges

  • Higher Expenditure Associated With Gastritis Treatment

High-end expenditures regarding the drug manufacturing and development process are hampering the market's growth. High initial investment required in the R&D activities for developing vaccines, drugs, and kits used in the treatment are restraining growth of the gastritis treatment market.

  • Unavailability of Appropriate Treatments

To treat conditions which are rare, many a times all treatments are not available, especially in the under-developed countries. The severe patients needs to be treated with advanced techniques but at times, these are not available in the hospitals and clinics. Thus, it hampers the market growth.

This global gastritis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global gastritis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Gastritis Market

 During the pandemic, it has been witnessed that gastrointestinal disorders are greatly associated with COVID-19 patients. The severity of COVID-19 is combined with a set of comorbidities such as diabetes, obesity, hypertension, and/or advanced age that seriously aggravates the consequences of the infection. Additionally, gastrointestinal symptoms, such as vomiting, diarrhea, or abdominal pain during the early phases of COVID-19 are also witnessed. Thus, diagnosing gastrointestinal symptoms that lead respiratory problems during COVID-19 became necessary for early detection and treatment. Thus, COVID-19 left a major impact on global gastritis market.

Global Gastritis Market Scope

The global gastritis market is segmented on the basis of treatment, route of administration, end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

  • Acid Blocking Medications
  • Prevacid 24HR (lansoprazole)
  • Nexium 24HR
  • Acid Reducing Medications
  • Nexium
  • Prevacid
  • Antacids
  • Aluminium hydroxide
  • Magnesium carbonate
  • Antibiotics
  • Amoxicillin
  • Doxycycline
  • Others

Type

  • Acute Gastritis
  • Chronic Gastritis
  • Erosive Gastritis
  • Non-Erosive Gastritis

Route of Administration

End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies
  • Others

Gastritis Market Regional Analysis/Insights

The global gastritis market is analyzed and market size insights and trends are provided by treatment, route of administration,end-user, distribution channel as referenced above.

The major countries covered in the global gastritis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is considered to have the highest lucrative growth in the forecast period to the increase prevalence of gastritis, vulnerable unhealthy lifestyles of the population and advanced healthcare facilities.

Asia-Pacific is dominating the market due to the increase’s cases of gastritis and rapidly aging population.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Gastritis Market Share Analysis

The global gastritis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global gastritis market.

Key players operating in the global gastritis market include:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • AstraZeneca (U.K.)
  • Johnson & Johnson Private Limited (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Merck & Co., Inc. (U.S.)
  • Lilly (U.S.)
  • Amgen Inc. (U.S.)
  • Dr. Reddy's Laboratories Ltd (India)
  • Endo International plc (Ireland)
  • Lupin (India)
  • Zydus Group (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The global gastritis market was USD 162.2 million in 2021.
The global gastritis market is projected to grow at a CAGR of 4% during the forecast period of 2022-2029.
North America is considered to have the highest lucrative growth in the forecast period to the increased prevalence of gastritis, vulnerable unhealthy lifestyles of the population, and advanced healthcare facilities.
Asia-Pacific is dominating the market due to the increase’s cases of gastritis and the rapidly aging population.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials